Optimizing Adherence to Antiretroviral Therapy

  • Author: Nancy Reynolds, PhD, RN, C-NP, FAAN (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 3/21/18 (What's New)

Summary

  • An assessment of adherence risk should be a routine component of the medical evaluation at baseline and follow-up
  • Baseline evaluation of HIV-infected patients should include an assessment of current or potential factors that might adversely affect medication adherence (Management Guidelines)[Thompson 2012]
  • Rate of adherence and factors that might adversely affect a patient’s medication adherence should be assessed every 3-6 months (Management Guidelines)[EACS ART]

    Action required

    Keywords: Adherence